Keyword

pasireotide

Description: A somatostatin-receptor-targeting pharmaceutical drug used to treat hormone-secreting pituitary tumors and related endocrine disorders.
Wikidata ID: wiki/Q3896970
OpenAlex ID: keywords/pasireotide
2017 · Mark E. Molitch · JAMA · 1,192
2012 · Annamaria Colao, Stephan Petersenn, et al. · New England Journal of Medicine · 679
2015 · Rosario Pivonello, Monica De Leo, et al. · Endocrine Reviews · 513
2014 · Peter J. Allen, Mithat Gönen, et al. · New England Journal of Medicine · 460
2019 · Annamaria Colao, Ludovica F. S. Grasso, et al. · Nature Reviews Disease Primers · 456
2009 · I. M. MODLIN, M. PAVEL, et al. · Alimentary Pharmacology & Therapeutics · 447
2014 · A. Colao, M. D. Bronstein, et al. · The Journal of Clinical Endocrinology & Metabolism · 439
2007 · Herbert A. Schmid · Molecular and Cellular Endocrinology · 302
2010 · Richard A. Feelders, Christiaan de Bruin, et al. · New England Journal of Medicine · 276
2013 · Robert R. Henry, Theodore P. Ciaraldi, et al. · The Journal of Clinical Endocrinology & Metabolism · 264
2010 · S. Petersenn, J. Schopohl, et al. · The Journal of Clinical Endocrinology & Metabolism · 217
2010 · Kjell E. Öberg, Jean–Claude Reubi, et al. · Gastroenterology · 216
2006 · Dalia L. Batista, Xun Zhang, et al. · The Journal of Clinical Endocrinology & Metabolism · 210
2004 · Leo J. Hofland, Joost van der Hoek, et al. · The Journal of Clinical Endocrinology & Metabolism · 198
2008 · Sarah Lesche, Diana Lehmann, et al. · The Journal of Clinical Endocrinology & Metabolism · 183
2017 · André Lacroix, Feng Gu, et al. · The Lancet Diabetes & Endocrinology · 176
Works count: 1,461
Citation count: 28,200
Year
Topic
Type